Metraipolis › archive › dc_a379da37f2f6
Complement C5 inhibition in generalized myasthenia gravis is associated with improved survival and increased cardiovascular risk — Europe PMC PMID:42220523
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42220523
- DOI
- 10.3389/fimmu.2026.1812643
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T08:28:26.487Z
- SHA-256 of the archived text
e6208e1d1c16d8126260a36d8eb25585ea63373ddc450d9e34690e840bacb0ac- Stable URL of this page
https://metraipolis.com/documento/dc_a379da37f2f6
How to cite
Complement C5 inhibition in generalized myasthenia gravis is associated with improved survival and increased cardiovascular risk — Europe PMC PMID:42220523 — Europe PMC (en), https://europepmc.org/article/MED/42220523 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a379da37f2f6 (Metraipolis archive dc_a379da37f2f6, sha256 e6208e1d1c16d8126260a36d8eb25585ea63373ddc450d9e34690e840bacb0ac)
BibTeX
@misc{dca379da37f2f6,
title = {Complement C5 inhibition in generalized myasthenia gravis is associated with improved survival and increased cardiovascular risk — Europe PMC PMID:42220523},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42220523},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a379da37f2f6; sha256 e6208e1d1c16d8126260a36d8eb25585ea63373ddc450d9e34690e840bacb0ac},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42220523. Agents can read the archived copy with the MCP tool read_document.